COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,387 Articles (22,816 medRxiv, 8,571 bioRxiv)

Most recent first Previous |  Page 2754: Articles 27531-27540  | Next

The SARS-CoV-2 cytopathic effect is blocked with autophagy modulators
Gorshkov, K., Chen, C. Z., Bostwick, R., Rasmussen, L., Xu, M., Pradhan, M., Tran, B. N., Zhu, W., Shamim, K., Huang, W., Hu, X., Shen, M., Klumpp-Thomas, C., Itkin, Z., Shinn, P., Simeonov, A., Michael, S., Hall, M. D., Lo, D. C., Zheng, W.
10.1101/2020.05.16.091520 — Posted: 2020-05-21 Discussion: Onsite | Offsite
Prevalence of facemask use among general public when visiting wet market during Covid-19 pandemic: An observational study.
Gunasekaran, G. H., Gunasekaran, S. S. S., Gunasekaran, S. S., Zaimi, N. S. I., Abdul Halim, N. A.
10.1101/2020.05.17.20105023 — Posted: 2020-05-21
Lung ultrasound findings in patients with novel SARS-CoV2
Haaksma, M. E., Heldeweg, M. L. A., Lopez Matta, J. E., Smit, J. M., van Trigt, J. D., Nooitgedacht, J. S., Elzo Kraemer, C. V., Girbes, A. R. J., Heunks, L. M. A., van Westerloo, D. J., Tuinman, P. R.
10.1101/2020.05.18.20105775 — Posted: 2020-05-21
COVID-19: the key role of pulmonary capillary leakage. An observational cohort study
Wu, M. A., Fossali, T., Pandolfi, L., Carsana, L., Ottolina, D., Frangipane, V., Rech, R., Tosoni, A., Agarossi, A., Cogliati, C., Meloni, F., Marchini, B., Nebuloni, M., Catena, E., Colombo, R.
10.1101/2020.05.17.20104877 — Posted: 2020-05-21
Development and Validation of Two In-house, Low-Cost SARS-CoV-2 Detection Assays
Alhamlan, F., Alqahtani, A., Bakheet, D., Bohol, M., Althawadi, S., Mutabagani, M., Almaghrabi, R., Obeid, D.
10.1101/2020.05.18.20105510 — Posted: 2020-05-21
Simulating the progression of the COVID-19 disease in Cameroon using SIR models
NGUEMDJO, U. K., MENO, F., DONGFACK, A., VENTELOU, B.
10.1101/2020.05.18.20105551 — Posted: 2020-05-21
An acceptable method to evaluate the analytical performance of real-time fluorescent RT-PCR targeting SARS-CoV-2
Ren, X.-d., Tang, Q.-M., Chen, M., Huang, Q., Huang, H.-L., Wang, L., Su, N., Sun, X.-G., Wei, K., Lu, W.-P., Deng, S.-L., Huang, Q.
10.1101/2020.05.18.20105247 — Posted: 2020-05-21
The Dynamic Changes of Antibodies against SARS-CoV-2 during the Infection and Recovery of COVID-19
Li, K., Wu, M., Huang, B., Zhong, A., Li, L., Cai, Y., Wu, L., Zhu, M., Li, J., Wang, Z., Wu, W., Li, W., Bosco, B., Gan, Z., Wang, Z., Qiao, Q., Wu, J., wang, q., Wang, S., Xia, X.
10.1101/2020.05.18.20105155 — Posted: 2020-05-21
Fuzzy Autocatalytic analysis of Covid-19 outbreak in Malaysia
Ahmad, T., Ashaari, A., Awang, S. R., Mamat, S. S., Wan Mohamad, W. M., Ahmad Fuad, A. A., Hassan, N.
10.1101/2020.05.17.20104968 — Posted: 2020-05-21
Modelling to Predict Hospital Bed Requirements for Covid-19 Patients in California
Basu, S.
10.1101/2020.05.17.20104919 — Posted: 2020-05-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).